Discontinuation report HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)

Last updated on 2023-10-19 History
Report ID 207275
Drug Identification Number 02303108
Brand name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Common or Proper name HEPARIN NA
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 10000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5ML 10LIVI
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2023-10-18
Remaining supply date 2023-10-18
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-10-18 English Compare
v2 2023-10-18 French Compare
v3 2023-10-19 English Compare

Showing 1 to 3 of 3